News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,836 Results
Type
Article (63416)
Company Profile (154)
Press Release (646265)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (187148)
Career Advice (2844)
Deals (34766)
Drug Delivery (116)
Drug Development (79888)
Employer Resources (166)
FDA (16387)
Job Trends (15359)
News (327834)
Policy (33095)
Tag
Academia (2879)
Academic (2)
Accelerated approval (11)
Adcomms (28)
Allergies (101)
Alliances (47799)
ALS (113)
Alzheimer's disease (1457)
Antibody-drug conjugate (ADC) (152)
Approvals (16380)
Artificial intelligence (344)
Autoimmune disease (32)
Automation (18)
Bankruptcy (328)
Best Places to Work (12059)
BIOSECURE Act (20)
Biosimilars (134)
Biotechnology (90)
Bladder cancer (95)
Brain cancer (38)
Breast cancer (372)
Cancer (2896)
Cardiovascular disease (223)
Career advice (2414)
Career pathing (34)
CAR-T (200)
CDC (37)
Cell therapy (532)
Cervical cancer (24)
Clinical research (65758)
Collaboration (1030)
Company closure (3)
Compensation (428)
Complete response letters (26)
COVID-19 (2792)
CRISPR (65)
C-suite (358)
Cystic fibrosis (116)
Data (3019)
Decentralized trials (2)
Denatured (34)
Depression (64)
Diabetes (346)
Diagnostics (6726)
Digital health (25)
Diversity (10)
Diversity, equity & inclusion (42)
Drug discovery (147)
Drug pricing (143)
Drug shortages (26)
Duchenne muscular dystrophy (124)
Earnings (67510)
Editorial (43)
Employer branding (20)
Employer resources (147)
Events (114201)
Executive appointments (907)
FDA (18114)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (967)
Gene editing (140)
Generative AI (27)
Gene therapy (382)
GLP-1 (795)
Government (5109)
Grass and pollen (6)
Guidances (181)
Healthcare (20091)
HIV (43)
Huntington's disease (27)
IgA nephropathy (37)
Immunology and inflammation (148)
Immuno-oncology (6)
Indications (40)
Infectious disease (2979)
Inflammatory bowel disease (156)
Inflation Reduction Act (13)
Influenza (70)
Intellectual property (124)
Interviews (545)
IPO (15964)
IRA (50)
Job creations (3721)
Job search strategy (2021)
Kidney cancer (14)
Labor market (48)
Layoffs (555)
Leadership (26)
Legal (7560)
Liver cancer (78)
Longevity (11)
Lung cancer (400)
Lymphoma (202)
Machine learning (10)
Management (59)
Manufacturing (392)
MASH (90)
Medical device (13872)
Medtech (13878)
Mergers & acquisitions (19543)
Metabolic disorders (856)
Multiple sclerosis (100)
NASH (17)
Neurodegenerative disease (112)
Neuropsychiatric disorders (33)
Neuroscience (2142)
NextGen: Class of 2025 (7068)
Non-profit (4953)
Now hiring (26)
Obesity (427)
Opinion (269)
Ovarian cancer (100)
Pain (113)
Pancreatic cancer (121)
Parkinson's disease (185)
Partnered (22)
Patents (310)
Patient recruitment (174)
Peanut (52)
People (61232)
Pharmaceutical (43)
Pharmacy benefit managers (24)
Phase I (20723)
Phase II (28827)
Phase III (21329)
Pipeline (1623)
Policy (227)
Postmarket research (2642)
Preclinical (8684)
Press Release (67)
Prostate cancer (143)
Psychedelics (43)
Radiopharmaceuticals (269)
Rare diseases (476)
Real estate (6258)
Recruiting (68)
Regulatory (23045)
Reports (38)
Research institute (2563)
Resumes & cover letters (422)
Rett syndrome (10)
RNA editing (7)
RSV (51)
Schizophrenia (88)
Series A (161)
Series B (113)
Service/supplier (11)
Sickle cell disease (65)
Special edition (16)
Spinal muscular atrophy (153)
Sponsored (34)
Startups (3605)
State (1)
Stomach cancer (11)
Supply chain (73)
Tariffs (54)
The Weekly (55)
Vaccines (866)
Venture capital (53)
Weight loss (259)
Women's health (50)
Worklife (20)
Date
Today (70)
Last 7 days (343)
Last 30 days (1817)
Last 365 days (31289)
2025 (17132)
2024 (34809)
2023 (39430)
2022 (50475)
2021 (55572)
2020 (54782)
2019 (48865)
2018 (37154)
2017 (32849)
2016 (32788)
2015 (38408)
2014 (31401)
2013 (27415)
2012 (28981)
2011 (29240)
2010 (27644)
Location
Africa (982)
Alabama (69)
Alaska (7)
Arizona (214)
Arkansas (13)
Asia (41663)
Australia (7394)
California (7194)
Canada (2338)
China (687)
Colorado (320)
Connecticut (330)
Delaware (189)
Europe (95102)
Florida (1100)
Georgia (259)
Hawaii (2)
Idaho (63)
Illinois (694)
India (28)
Indiana (370)
Iowa (16)
Japan (227)
Kansas (108)
Kentucky (31)
Louisiana (15)
Maine (73)
Maryland (1021)
Massachusetts (5376)
Michigan (260)
Minnesota (440)
Mississippi (3)
Missouri (102)
Montana (31)
Nebraska (25)
Nevada (81)
New Hampshire (71)
New Jersey (2090)
New Mexico (30)
New York (2084)
North Carolina (1116)
North Dakota (10)
Northern California (3134)
Ohio (234)
Oklahoma (17)
Oregon (37)
Pennsylvania (1549)
Puerto Rico (17)
Rhode Island (34)
South America (1298)
South Carolina (30)
South Dakota (1)
Southern California (2714)
Tennessee (127)
Texas (1099)
United States (27273)
Utah (229)
Virginia (187)
Washington D.C. (75)
Washington State (641)
West Virginia (4)
Wisconsin (77)
709,836 Results for "national institutes of health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test
July 15, 2025
·
5 min read
Press Releases
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
July 4, 2025
·
5 min read
Press Releases
Galderma’s Nemluvio® (nemolizumab) Receives National Institute for Health and Care Excellence (NICE) Recommendation for Moderate-to-severe Atopic Dermatitis in England and Wales
June 12, 2025
·
9 min read
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Press Releases
Statens Serum Institut Large Danish Study Finds No Link Between Vaccines and Autism or 49 Other Health Conditions
July 16, 2025
·
2 min read
Press Releases
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025
·
12 min read
Press Releases
Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
January 23, 2025
·
10 min read
Business
The Foundation for the National Institutes of Health Appoints Love Collins, III to Lead Advancement and Development
The Foundation for the National Institutes of Health announces that Love Collins, III, has joined as Vice President of Advancement.
May 13, 2024
·
3 min read
Business
The Foundation for the National Institutes of Health Appoints James W. Down and Perry Steiner to Its Board of Directors
The Foundation for the National Institutes of Health announces two additions to the FNIH Board of Directors: James W. Down, former Vice Chairman of Mercer Management Consulting, and Perry Steiner, Chairman and CEO of Xactus.
May 29, 2024
·
3 min read
Biotech Bay
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology
Kyverna Therapeutics, Inc. announced the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled “Chimeric antigen receptor T cell therapy for autoimmune disease”.
June 10, 2024
·
5 min read
1 of 70,984
Next
